Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome
Exosome is an excellent vesicle for in vivo delivery of therapeutics, including RNAi and chemical drugs. The extremely high efficiency in cancer regression can partly be attributed to its fusion mechanism in delivering therapeutics to cytosol without endosome trapping. However, being composed of a l...
Saved in:
Main Authors: | Nasir Uddin (Author), Daniel W. Binzel (Author), Dan Shu (Author), Tian-Min Fu (Author), Peixuan Guo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rational design for controlled release of Dicer-substrate siRNA harbored in phi29 pRNA-based nanoparticles
by: Daniel W. Binzel, et al.
Published: (2021) -
Targeting oncogenic KRAS in non-small cell lung cancer with EGFR aptamer-conjugated multifunctional RNA nanoparticles
by: Linlin Yang, et al.
Published: (2023) -
Introduction to RNAi and miRNA pathways
by: Petr Svoboda
Published: (2020) -
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
by: Achim Aigner, et al.
Published: (2011) -
Delivery of RNAi-Based Oligonucleotides by Electropermeabilization
by: Muriel Golzio, et al.
Published: (2013)